sellWeak10b5-1 plan
RIKER LAUREN sold $218k of PCRX
Senior Vice President, Finance at Pacira BioSciences, Inc.. 6,000 shares at an average of $36.32, traded Oct 8, 2026, filed Oct 9, 2026.
Warning score
0Value
$218k
6,000 shares
Holdings after
62,284
-9% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001628280-26-065566, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 8, 2026 | MOption exercise Common Stock10b5-1 | +6,000 | $32.35 | $194k | 68,284 | 27 h ago |
| Oct 8, 2026 | SOpen-market sale Common Stock10b5-1 | -6,000 | $36.32 | $218k | 62,284 | 27 h ago |
| Oct 8, 2026 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,000 | $0.00 | $0 | 0 | 27 h ago |
Related signals
Other insiders at Pacira BioSciences, Inc. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 0Weak | sell10b5-1 | PCRX Pacira BioSciences, Inc. | GAUGLER DARYL Chief Operating Officer | $9,880 | 500 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.